Codexis Inc
NASDAQ:CDXS
Codexis Inc
Cash from Operating Activities
Codexis Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Codexis Inc
NASDAQ:CDXS
|
Cash from Operating Activities
-$52.6m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-9%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Operating Activities
$756.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Codexis Inc's Cash from Operating Activities?
Cash from Operating Activities
-52.6m
USD
Based on the financial report for Dec 31, 2023, Codexis Inc's Cash from Operating Activities amounts to -52.6m USD.
What is Codexis Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-9%
The average annual Cash from Operating Activities growth rates for Codexis Inc have been -47% over the past three years , -30% over the past five years , and -9% over the past ten years .